Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned persons hereby agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock, par value $0.0013 per share of Progenics Pharmaceuticals, Inc. and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing. In evidence thereof each of the undersigned, being duly authorized, hereby execute this Agreement on the date set forth below.
Date: April 9, 2020
| VELAN CAPITAL, L.P. | |||
| By: | Altiva Management Inc., its general partner | ||
| By: | /s/ Stephanie P. Cooper | ||
| Name: | Stephanie P. Cooper | ||
| Title: | President and Secretary | ||
| ALTIVA MANAGEMENT INC. | |||
| By: | /s/ Stephanie P. Cooper | ||
| Name: | Stephanie P. Cooper | ||
| Title: | President and Secretary | ||
| VELAN CAPITAL PARTNERS LP | |||
| By: | Velan Capital Holdings LLC, its general partner | ||
| By: | /s/ Deepak Sarpangal | ||
| Name: | Deepak Sarpangal | ||
| Title: | Managing Member | ||
| VELAN CAPITAL HOLDINGS LLC | |||
| By: | /s/ Deepak Sarpangal | ||
| Name: | Deepak Sarpangal | ||
| Title: | Managing Member | ||
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | |||
| By: | Velan Capital Management LLC, its general partner | ||
| By: | /s/ Balaji Venkataraman | ||
| Name: | Balaji Venkataraman | ||
| Title: | Managing Member | ||
| VELAN PRINCIPALS GP LLC | |||
| By: | /s/ Balaji Venkataraman | ||
| Name: | Balaji Venkataraman | ||
| Title: | Managing Member | ||
| VELAN CAPITAL MANAGEMENT LLC | |||
| By: | /s/ Balaji Venkataraman | ||
| Name: | Balaji Venkataraman | ||
| Title: | Managing Member | ||
/s/ Balaji Venkataraman | |
| BALAJI VENKATARAMAN |
/s/ Deepak Sarpangal | |
| DEEPAK SARPANGAL |
